-
1
-
-
0035005122
-
Transfusion therapy: A coming-of-age treatment for patients with sickle cell disease
-
Reed W, Vichinsky EP. Transfusion therapy: A coming-of-age treatment for patients with sickle cell disease. J Pediatr Hematol Oncol 2001; 23: 197-202.
-
(2001)
J Pediatr Hematol Oncol
, vol.23
, pp. 197-202
-
-
Reed, W.1
Vichinsky, E.P.2
-
2
-
-
0025155742
-
Transfusion and alloimmunization in sickle cell disease
-
Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. Blood 1990; 76: 1431-1437.
-
(1990)
Blood
, vol.76
, pp. 1431-1437
-
-
Rosse, W.F.1
Gallagher, D.2
Kinney, T.R.3
-
3
-
-
0023743090
-
Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease
-
Cox JV, Steane E, Cunningham G, et al. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988; 148: 2485-2489.
-
(1988)
Arch Intern Med
, vol.148
, pp. 2485-2489
-
-
Cox, J.V.1
Steane, E.2
Cunningham, G.3
-
4
-
-
0025372673
-
Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood
-
Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322: 1617-1621.
-
(1990)
N Engl J Med
, vol.322
, pp. 1617-1621
-
-
Vichinsky, E.P.1
Earles, A.2
Johnson, R.A.3
-
5
-
-
0034858110
-
Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial
-
Vichinsky EP, Luban NLC, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial. Transfusion 2001; 41: 1086-1092.
-
(2001)
Transfusion
, vol.41
, pp. 1086-1092
-
-
Vichinsky, E.P.1
Luban, N.L.C.2
Wright, E.3
-
7
-
-
0032950197
-
Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: Frequency, characteristics and significance
-
Castellino SM, Combs MR, Zimmerman SA, et al. Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: Frequency, characteristics and significance. Br J Haematol 1999; 104: 189-194.
-
(1999)
Br J Haematol
, vol.104
, pp. 189-194
-
-
Castellino, S.M.1
Combs, M.R.2
Zimmerman, S.A.3
-
8
-
-
0036360040
-
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions
-
Aygun B, Padmanabhan S, Paley C, et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002; 42: 37-43.
-
(2002)
Transfusion
, vol.42
, pp. 37-43
-
-
Aygun, B.1
Padmanabhan, S.2
Paley, C.3
-
9
-
-
79958825184
-
-
35th Anniversary Convention of the National Sickle Cell Disease Program and the Sickle Cell Disease Association of America, Inc., 2007; abstract 285.
-
Smith-Whitley K, Kwiatkowski J, Ohene-Frempong K. 35th Anniversary Convention of the National Sickle Cell Disease Program and the Sickle Cell Disease Association of America, Inc., 2007; abstract 285.
-
-
-
Smith-Whitley, K.1
Kwiatkowski, J.2
Ohene-Frempong, K.3
-
10
-
-
79958851172
-
-
American Society of Hematology annual meeting 2007; abstract 3389.
-
Ambruso DR, LaSalle-Williams M, Le T, et al. American Society of Hematology annual meeting 2007; abstract 3389.
-
-
-
Ambruso, D.R.1
LaSalle-Williams, M.2
Le, T.3
-
11
-
-
33644867082
-
Red blood cell alloantibodies after transfusion: Factors influencing incidence and specificity
-
Schonewille H, van de Watering LMG, Loomans DES, et al. Red blood cell alloantibodies after transfusion: Factors influencing incidence and specificity. Transfusion 2006; 46: 250-256.
-
(2006)
Transfusion
, vol.46
, pp. 250-256
-
-
Schonewille, H.1
van de Watering, L.M.G.2
Loomans, D.E.S.3
-
12
-
-
0027958085
-
Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease
-
Kim HC, Dugan NP, Silber JH, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994; 83: 1136-1142.
-
(1994)
Blood
, vol.83
, pp. 1136-1142
-
-
Kim, H.C.1
Dugan, N.P.2
Silber, J.H.3
-
13
-
-
0032735280
-
Erythrocytapheresis for chronically transfused children with sickle cell disease: An effective method for maintaining a low hemoglobin S level and reducing iron overload
-
Singer ST, Quirolo K, Nishi K, et al. Erythrocytapheresis for chronically transfused children with sickle cell disease: An effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apheresis 1999; 14: 122-125.
-
(1999)
J Clin Apheresis
, vol.14
, pp. 122-125
-
-
Singer, S.T.1
Quirolo, K.2
Nishi, K.3
-
14
-
-
1242340366
-
Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood
-
Thurston GB, Henderson NM, Jeng M. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood. Clin Hemorheol Microcirc 2004; 30: 83-97.
-
(2004)
Clin Hemorheol Microcirc
, vol.30
, pp. 83-97
-
-
Thurston, G.B.1
Henderson, N.M.2
Jeng, M.3
-
15
-
-
77952595068
-
The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults
-
Kalff A, Dowsing C, Grigg A. The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults. Br J Haematol 2010; 149: 768-774.
-
(2010)
Br J Haematol
, vol.149
, pp. 768-774
-
-
Kalff, A.1
Dowsing, C.2
Grigg, A.3
|